87 percent of laboratory staff globally have at least one cell culture contamination event per year

Researchers reveal novel technique using 'floating liquid marbles' to tackle paralysis

More than half of biomedical researchers today do not authenticate their cell lines; Cite cost and time constraints as main barriers to making authentication routine

The most significant equipment-related trend in bioprocessing over the past 15 years has been the replacement of reusable glass and steel equipment by single-use plastics.

Cell culture today presents a subtle paradox. Coaxing cells to produce biopharmaceuticals, vitamins, and industrial products requires inserting foreign genes and adapting cells to artificial growth conditions.

Spinout’s microfluidics device better models how cancer and other cells interact in the body.

The EVOM2 is the ideal meter for use when you are making manual TEER measurements on small batches of cell cultures and do not require a high throughput system.

Researcher studies ways to improve the latest offerings to better mimic the human body  

The vast majority of the thousands of chemicals in our homes and workplaces have not been tested to determine if they cause cancer. That’s because today’s options are lacking. Rodent tests are too slow, and cell culture tests don’t replicate how cells interact in the body, so their relevance to cancer is limited. Scientists from the U.S. Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) have set out to change that.

A new study led by researchers at The Scripps Research Institute (TSRI) and the University of California (UC), San Diego School of Medicine shows that certain stem cell culture methods are associated with increased DNA mutations. The study points researchers toward safer and more robust methods of growing stem cells to treat disease and injury.